EUVIMEDOpdag EUVIMED
Vergleichsstudie

Endoscopic Resection Versus Surgical Resection for T1/T2 Duodenal Adenocarcinoma: Considerations of Nodal Upstaging

Bryant Morocho iD, Abdul S Calvino, Ponnandai Somasundar, Steve Kwon

Journal of Surgical Oncology · 2026-04 · 133 (5) · 632-641

DOI: 10.1002/jso.70204 ↗

At a glance

Vergleichsstudie in Journal of Surgical Oncology, published online on 2026-02-15. Written by Bryant Morocho and 3 co-authors. Institution: Department of Surgery, Division of Surgical Oncology, Roger Williams Medical Center, Providence, Rhode Island, USA. Major MEDLINE topics: Duodenal Neoplasms, Adenocarcinoma. Cited 1 times so far (Crossref); 46 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Objective Endoscopic resection (ER) is increasingly used for early‐stage duodenal adenocarcinoma (DA). This study aimed to identify factors guiding ER selection for clinical T1/T2N0 DA.

Methods

A retrospective National Cancer Database analysis (2010–2021) included patients with clinical T1/T2N0M0 DA with available pathological staging among those who underwent surgical resection. Outcomes were overall survival and lymph node upstaging (LNU). Survival was evaluated using Cox proportional hazard models, and predictors of LNU were assessed using logistic regression.

Results

Among 527 patients, 68 underwent ER and 459 underwent a major resection. Overall survival did not differ between the two groups (HR: 0.96, 95% CI: 0.65–1.40). Among major resections, nodal upstaging occurred in about 40% of patients and was associated with worse survival (T1 HR: 1.72, 95% CI: 1.18–2.50) and (T2 HR: 2.06, 95% CI: 1.28–3.33). Poor differentiation (OR: 2.83, 95% CI: 1.08–7.45), lymphovascular invasion (OR 7.19, 95% CI: 4.48–11.53), and age (≥ 80 compared to < 65—OR: 0.40, 95% CI: 0.20–0.82) were significant predictors of LNU.

Conclusion

Nearly 40% of clinically node‐negative T1/T2 DA patients who underwent a major resection had LNU, which was associated with worse overall survival. Pathologic features should guide ER selection.

Subjects

MeSH terms (MEDLINE)

Duodenal NeoplasmsAdenocarcinomaHumansRetrospective StudiesFemaleNeoplasm StagingMaleAgedMiddle AgedLymphatic MetastasisSurvival RateLymph Nodes

Author keywords

ERduodenal adenocarcinomaendoscopic resectionupstaging

Authors and institutions

  • Department of Surgery, Division of Surgical Oncology, Roger Williams Medical Center, Providence, Rhode Island, USA.
  • Roger Williams Surgery and Cancer Outcomes Research and Equity (RWSCORE) Center, Roger Williams Medical Center, Providence, Rhode Island, USA.
  • Department of Surgery, Boston University School of Medicine, Boston, Massachusetts, USA.

ORCID profiles: Bryant Morocho

Cite

APA

Morocho, B., Calvino, A. S., Somasundar, P., & Kwon, S. (2026). Endoscopic Resection Versus Surgical Resection for T1/T2 Duodenal Adenocarcinoma: Considerations of Nodal Upstaging. Journal of Surgical Oncology, 133(5), 632-641. https://doi.org/10.1002/jso.70204

Vancouver

Morocho B, Calvino AS, Somasundar P, Kwon S. Endoscopic Resection Versus Surgical Resection for T1/T2 Duodenal Adenocarcinoma: Considerations of Nodal Upstaging. Journal of Surgical Oncology. 2026;133(5):632-641. doi:10.1002/jso.70204

BibTeX
@article{Morocho2026,
  author = {Morocho, Bryant and Calvino, Abdul S and Somasundar, Ponnandai and Kwon, Steve},
  title = {Endoscopic Resection Versus Surgical Resection for T1/T2 Duodenal Adenocarcinoma: Considerations of Nodal Upstaging},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  volume = {133},
  number = {5},
  pages = {632--641},
  doi = {10.1002/jso.70204}
}
Start for free →